Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study.
Donald A MahlerHenrik WatzRachel Emerson-StadlerJohn RitzAsparuh GardevAsif ShaikhM Bradley DrummondPublished in: International journal of chronic obstructive pulmonary disease (2023)
As indicated in COPD management guidelines, choice of inhaler is essential to optimize pharmacologic therapies for COPD. Poor inspiratory ability should be viewed as a treatable trait that can help to inform inhaler choice. Inhaler training and consideration of PIF (if patients use a dry powder inhaler) can reduce patient-to-inhaler mismatch, with potential consequences for health status and exacerbation risk.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- case report
- gene expression
- clinical practice
- risk assessment
- cystic fibrosis
- decision making
- intensive care unit
- air pollution
- mechanical ventilation
- breast cancer risk